PKI Stock: PerkinElmer, Inc. Stock Price, Analysis & Insights
Get live pki stock price $115.24, comprehensive PerkinElmer, Inc. stock analysis, charts, news, and expert forecast. Real-time pki stock data and investment insights.
Loading chart...
Company Overview
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Company Information
- CEO
- Prahlad R. Singh
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 16700
Contact Information
- Website
- https://www.perkinelmer.com
- Address
- 940 Winter Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 41.5)
Business Model & Strategy
PerkinElmer, Inc. operates in the Medical - Diagnostics & Research industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Prahlad R. Singh, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Diagnostics & Research model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
PerkinElmer, Inc. competes in the Medical - Diagnostics & Research within the broader Healthcare. With 14.5 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, PerkinElmer, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating PerkinElmer, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for PerkinElmer, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for PerkinElmer, Inc.
- ⚠Investors should consider how PerkinElmer, Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 41.5) requires strong growth to justify
Market Cap
14.46B
P/E Ratio
41.45
Beta
1.10
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 14.46B market capitalization
- Trading Volume: 1.63M shares traded today
- Price Range: 52-week range of $113.17 - $170.00
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for PerkinElmer, Inc.
PerkinElmer, Inc. (PKI) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 14.46B, the company represents a significant player in its market. The stock is currently trading at $115.24 with a negativedaily change of 0.91%.
The company's 16700 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 41.45, beta of 1.10, and 52-week price range from $113.17 to $170.00when evaluating investment opportunities.
Why Invest in PerkinElmer, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Prahlad R. Singh
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.